• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prophylactic hemodialysis in the treatment of acute renal failure. Annals of Internal Medicine, 53:992-1016, 1960.

作者信息

Teschan P E, Baxter C R, O'Brien T F, Freyhof J N, Hall W H

机构信息

Renal Branch, U.S. Army Surgical Research Unit, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

出版信息

J Am Soc Nephrol. 1998 Dec;9(12):2384-97. doi: 10.1681/ASN.V9122384.

DOI:10.1681/ASN.V9122384
PMID:9848796
Abstract

Prophylactic hemodialysis has been employed in the treatment of 15 patients with acute renal failure due to acute tubular necrosis (12), bilateral renal cortical necrosis (two), and poststreptococcal glomerulonephritis (one). Dialyses, usually lasting six hours each, were begun before clinical evidence of uremia developed in each patient and/or before the nonprotein nitrogen reached 200 mg.%, and were repeated daily or often enough to maintain the nonprotein nitrogen below 150 mg.%. The hypothesis underlying this technic postulates (1) that wasting, sepsis and impaired wound healing in these patients may reflect tissue injury by the same dialyzable toxic agents which produce the uremic symptoms that are readily reversible by dialysis, and (2) that repeated dialyses should therefore prevent both clinical uremia and the later, often lethal sequelae. The results contrast dramatically with our own past experience in treating patients with acute renal failure with a carefully executed medical regimen together with hemodialysis on conventional indications. Except in one instance of crush injury with progressive intracerebral damage, and one brief occasion in another individual, these patients experienced a stable, convalescent clinical course, remained free of uremic symptoms or chemical imbalances, ate at least three meals daily which were unrestricted in amount and composition, and were ambulatory between dialyses unless confined to bed by associated disease. Wounds healed well. Infection either did not occur, or subsided after appropriate therapy. Fluid restriction was liberalized by means of ultrafiltration with dialysis. Regional heparinization of only the extracorporeal circuit eliminated actual or impending bleeding as a contraindication to dialysis. Chronic vessel cannulation made the frequent dialyses possible, but may have provided the route for repeated, transient bacterial contamination of the blood stream in the first hour of many dialyses. Marked anemia, despite reticulocytosis, moderate to mild weight loss and some mental deficit persisted in spite of the general clinical improvement and well-being. Three patients with tubular necrosis died after seven, 11 and 26 days of oliguria; both patients with bilateral renal cortical necrosis also succumbed, on the seventy-third and ninety-second days of renal failure, and after 29 and 40 dialyses, respectively. At autopsy, evidence of sepsis was conspicuously absent. The remaining 10 patients survived. Thus some, but not all, clinical manifestations of acute renal failure appear to be favorably influenced by prophylactic dialysis treatment. Our initial experience in this group of 15 patients does not of course prove that freedom from complications and a significantly better outlook for survival can be assured to patients with acute renal failure by these methods. However, it seems to offer a reasonable hope of this possibility which we cannot attach to management by medical measures alone, or by dialysis on conventional indications. If this hope is realized in greatly extended, subsequent series, then it seems inevitable that some form of prophylactic dialysis, or some equally effective alternative, should be adopted in treating the majority of patients with acute renal failure.

摘要

相似文献

1
Prophylactic hemodialysis in the treatment of acute renal failure. Annals of Internal Medicine, 53:992-1016, 1960.
J Am Soc Nephrol. 1998 Dec;9(12):2384-97. doi: 10.1681/ASN.V9122384.
2
Acute renal failure: the dawn of dialysis and the roaring 50s.
Nephrol Dial Transplant. 1994;9 Suppl 4:1-8.
3
The birth of the new idea called "prophylactic daily dialysis" for the treatment of acute renal failure.用于治疗急性肾衰竭的“每日预防性透析”这一新理念的诞生。
ASAIO Trans. 1989 Jan-Mar;35(1):2-4.
4
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
5
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
6
Daily hemodialysis and the outcome of acute renal failure.每日血液透析与急性肾衰竭的预后
N Engl J Med. 2002 Jan 31;346(5):305-10. doi: 10.1056/NEJMoa010877.
7
[Renal replacement therapy by hemodialysis: an overview].[血液透析的肾脏替代治疗:概述]
Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28.
8
Acute renal failure during the Korean War.朝鲜战争期间的急性肾衰竭。
Ren Fail. 1992;14(3):237-9. doi: 10.3109/08860229209106623.
9
[History of acute kidney injury, the early development of hemodialysis in France].[急性肾损伤的历史,法国血液透析的早期发展]
Nephrol Ther. 2012 Jul;8(4):240-5. doi: 10.1016/j.nephro.2011.12.001. Epub 2012 Feb 23.
10
Acute renal failure in the newborn.新生儿急性肾衰竭
Semin Perinatol. 2004 Apr;28(2):112-23. doi: 10.1053/j.semperi.2003.11.003.

引用本文的文献

1
French patients on daily hemodialysis: clinical characteristics and treatment trajectories.接受每日血液透析的法国患者:临床特征与治疗轨迹
BMC Nephrol. 2016 Jul 29;17(1):107. doi: 10.1186/s12882-016-0306-7.
2
An insight into the sites of noncuffed hemodialysis catheters.对无袖血液透析导管置入部位的深入了解。
Indian J Nephrol. 2015 Sep-Oct;25(5):261-2. doi: 10.4103/0971-4065.152729.